Cite
HARVARD Citation
Oosting, S. et al. (n.d.). A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer. Oral oncology. pp. 43-49. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Oosting, S. et al. (n.d.). A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer. Oral oncology. pp. 43-49. [Online].